120 related articles for article (PubMed ID: 31375726)
21. Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
Cui J; Forbes A; Kirby A; Simes J; Tonkin A
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):660-8. PubMed ID: 19738473
[TBL] [Abstract][Full Text] [Related]
22. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
23. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.
Wallisch C; Heinze G; Rinner C; Mundigler G; Winkelmayer WC; Dunkler D
Int J Cardiol; 2019 May; 283():165-170. PubMed ID: 30429082
[TBL] [Abstract][Full Text] [Related]
24. Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics.
Backholer K; Hirakawa Y; Tonkin A; Giles G; Magliano DJ; Colagiuri S; Harris M; Mitchell P; Nelson M; Shaw JE; Simmons D; Simons L; Taylor A; Harding J; Gopinath B; Woodward M
BMC Cardiovasc Disord; 2017 Jan; 17(1):17. PubMed ID: 28061760
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
[TBL] [Abstract][Full Text] [Related]
26. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
27. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population.
Wang A; Liu X; Xu J; Han X; Su Z; Chen S; Zhang N; Wu S; Wang Y; Wang Y
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29187392
[TBL] [Abstract][Full Text] [Related]
28. Chromosome 9p21 genetic variation explains 13% of cardiovascular disease incidence but does not improve risk prediction.
Gränsbo K; Almgren P; Sjögren M; Smith JG; Engström G; Hedblad B; Melander O
J Intern Med; 2013 Sep; 274(3):233-40. PubMed ID: 23480785
[TBL] [Abstract][Full Text] [Related]
29. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
[TBL] [Abstract][Full Text] [Related]
30. Comparison Between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol to Estimate Cardiovascular Risk Using a Multivariate Model.
Palazón-Bru A; Carbayo-Herencia JA; Simarro-Rueda M; Artigao-Ródenas LM; Divisón-Garrote JA; Molina-Escribano F; Ponce-García I; Gil-Guillén VF;
J Cardiovasc Nurs; 2018; 33(6):E17-E23. PubMed ID: 30273261
[TBL] [Abstract][Full Text] [Related]
31. Framingham, ACC/AHA or QRISK3: which is the best in systemic lupus erythematosus cardiovascular risk estimation?
Di Battista M; Tani C; Elefante E; Chimera D; Carli L; Ferro F; Stagnaro C; Mosca M
Clin Exp Rheumatol; 2020; 38(4):602-608. PubMed ID: 31694741
[TBL] [Abstract][Full Text] [Related]
32. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
33. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
[TBL] [Abstract][Full Text] [Related]
34. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.
Damen JA; Pajouheshnia R; Heus P; Moons KGM; Reitsma JB; Scholten RJPM; Hooft L; Debray TPA
BMC Med; 2019 Jun; 17(1):109. PubMed ID: 31189462
[TBL] [Abstract][Full Text] [Related]
35. Dietary information improves cardiovascular disease risk prediction models.
Baik I; Cho NH; Kim SH; Shin C
Eur J Clin Nutr; 2013 Jan; 67(1):25-30. PubMed ID: 23149979
[TBL] [Abstract][Full Text] [Related]
36. Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study.
Selak V; Jackson R; Poppe K; Wu B; Harwood M; Grey C; Pylypchuk R; Mehta S; Kerr A; Wells S
Ann Intern Med; 2019 Mar; 170(6):357-368. PubMed ID: 30802900
[TBL] [Abstract][Full Text] [Related]
37. A cardiovascular risk prediction model for older people: Development and validation in a primary care population.
van Bussel EF; Richard E; Busschers WB; Steyerberg EW; van Gool WA; Moll van Charante EP; Hoevenaar-Blom MP
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1145-1152. PubMed ID: 31294917
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
39. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
[TBL] [Abstract][Full Text] [Related]
40. Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study.
Puddu PE; Lanti M; Menotti A; Mancini M; Zanchetti A; Cirillo M; Angeletti M;
Acta Cardiol; 2002 Jun; 57(3):177-85. PubMed ID: 12088175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
